Trial Profile
A Study Assessing the Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Type 1 Diabetes Mellitus (T1DM) Patients due to Poor Glycemic Control
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2018
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 04 Apr 2018 New trial record